Clinical Trial

Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated March 18, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Patients with central serous chorioretinopathy (CSC) will be monitored with laser speckle flow graphy (LSFG), swept source optical coherence tomography (SS-OCT) and SS-OCT angiography (SS-OCTA). The aim is to unveil the flow and pulse wave characteristics of the choroidal circulation in acute CSC and chronic CSC.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05589974
Lead Sponsor Helse Stavanger HF
Conditions Central Serous Chorioretinopathy
Enrollment 50 participants
Start Date 2022-10-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2024-03-18